185 related articles for article (PubMed ID: 35494011)
1. Racial/Ethnic Differences in Health-Related Quality of Life Among Gay and Bisexual Prostate Cancer Survivors.
Bates AJ; Rosser BRS; Polter EJ; Wheldon CW; Talley KMC; Haggart R; Wright M; Mitteldorf D; West W; Ross MW; Konety BR; Kohli N
Front Oncol; 2022; 12():833197. PubMed ID: 35494011
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life by human immunodeficiency virus status in a cross-sectional survey of gay and bisexual prostate cancer survivors.
Polter EJ; Wheldon CW; Rosser BRS; Kohli N; Capistrant BD; Kapoor A; Konety B; Mitteldorf D; Ross M; Talley KMC; Terveen L; West W; Wright MM
Psychooncology; 2019 Dec; 28(12):2351-2357. PubMed ID: 31518042
[TBL] [Abstract][Full Text] [Related]
3. Military service and health-related quality of life among gay and bisexual prostate cancer survivors: Results from the
Bates AJ; Mitteldorf D; Rosser BRS; Wheldon CW; Polter EJ; Ross MW; Talley KMC; Haggart R; Wright MM; West W; Konety BR
BMJ Mil Health; 2024 Mar; ():. PubMed ID: 38548328
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Variation in Health-Related Quality of Life Scores Prior to Prostate Cancer Treatment.
Reading SR; Porter KR; Slezak JM; Harrison TN; Gelfond JS; Chien GW; Jacobsen SJ
Sex Med; 2017 Dec; 5(4):e219-e228. PubMed ID: 28827045
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic differences in health-related quality of life among female breast cancer survivors: cross-sectional findings from the Medical Expenditure Panel Survey.
Jackson I; Rowan P; Padhye N; Hwang LY; Vernon SW
Public Health; 2021 Jul; 196():74-81. PubMed ID: 34161858
[TBL] [Abstract][Full Text] [Related]
6. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
[TBL] [Abstract][Full Text] [Related]
7. Health Disparities of Sexual Minority Patients Following Prostate Cancer Treatment: Results From the
Rosser BRS; Polter EJ; Talley KMC; Wheldon CW; Haggart R; Wright M; West W; Mitteldorf D; Ross MW; Konety BR; Kohli N
Front Oncol; 2022; 12():812117. PubMed ID: 35186749
[TBL] [Abstract][Full Text] [Related]
8. Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers.
Hart TL; Coon DW; Kowalkowski MA; Zhang K; Hersom JI; Goltz HH; Wittmann DA; Latini DM
J Sex Med; 2014 Sep; 11(9):2308-17. PubMed ID: 24888965
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity Prevalence and Impact on Quality of Life in Gay and Bisexual Men Following Prostate Cancer Treatment.
Haggart R; Polter E; Ross M; Kohli N; Konety BR; Mitteldorf D; West W; Rosser BRS
Sex Med; 2021 Dec; 9(6):100439. PubMed ID: 34634579
[TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men with Heterosexual Men.
Ussher JM; Perz J; Kellett A; Chambers S; Latini D; Davis ID; Rose D; Dowsett GW; Williams S
J Sex Med; 2016 Mar; 13(3):425-34. PubMed ID: 26853048
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
14. The Sexual Functioning of Gay and Bisexual Men Following Prostate Cancer Treatment: Results from the Restore Study.
Rosser BRS; Kohli N; Polter EJ; Lesher L; Capistrant BD; Konety BR; Mitteldorf D; West W; Dewitt J; Kilian G
Arch Sex Behav; 2020 Jul; 49(5):1589-1600. PubMed ID: 31016492
[TBL] [Abstract][Full Text] [Related]
15. Intersectionality and cancer survivorship: Sexual orientation and racial/ethnic differences in physical and mental health outcomes among female and male cancer survivors.
Boehmer U; Jesdale BM; Streed CG; Agénor M
Cancer; 2022 Jan; 128(2):284-291. PubMed ID: 34499367
[TBL] [Abstract][Full Text] [Related]
16. Sexual Identity and Racial/Ethnic Differences in Awareness of Heart Attack and Stroke Symptoms: Findings From the National Health Interview Survey.
Caceres BA; Turchioe MR; Pho A; Koleck TA; Creber RM; Bakken SB
Am J Health Promot; 2021 Jan; 35(1):57-67. PubMed ID: 32551829
[TBL] [Abstract][Full Text] [Related]
17. Quality-of-life outcomes in men treated for localized prostate cancer.
Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Leach GE; Brook RH
JAMA; 1995 Jan; 273(2):129-35. PubMed ID: 7799493
[TBL] [Abstract][Full Text] [Related]
18. Prospective quality of life in men choosing open vs. robotic radical prostatectomy: long-term results from a racially diverse multi-institutional database.
Kord E; Jung N; Boehm B; Conti G; Kuo HC; Frankel J; Flores J; Levie K; Ho O; Elsamanoudi S; Jiang J; Stroup SP; Musser J; Ernest A; Speir R; Chesnut G; Tausch TJ; Porter C
World J Urol; 2022 Jun; 40(6):1427-1436. PubMed ID: 35279731
[TBL] [Abstract][Full Text] [Related]
19. Substance Use Disparities at the Intersection of Sexual Identity and Race/Ethnicity: Results from the 2015-2018 National Survey on Drug Use and Health.
Schuler MS; Prince DM; Breslau J; Collins RL
LGBT Health; 2020; 7(6):283-291. PubMed ID: 32543315
[No Abstract] [Full Text] [Related]
20. A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.
Caumont F; Conti G; Hurwitz LM; Kuo C; Levie KE; Badiozamani K; Frankel JK; Flores JP; Brand TC; Chaurasia A; Rosner IL; Stroup SP; Musser JE; Cullen J; Porter CR
Urol Oncol; 2020 Oct; 38(10):794.e1-794.e9. PubMed ID: 32139288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
